An editorial by Dr. John S. Macdonald, Aptium Oncology's Chief Medical Officer, was recently published in the GI Cancer Research Journal, the official journal of the International Society of Gastrointestinal Oncology. The editorial is titled Adopting Postoperative Chemoradiotherapy in Resected Gastric Cancer.
